▶ 調査レポート

世界のイマザピルAPI市場(~2028年):含有量98%、含有量95%

• 英文タイトル:Global Imazapyr API Market Insights, Forecast to 2028

Global Imazapyr API Market Insights, Forecast to 2028「世界のイマザピルAPI市場(~2028年):含有量98%、含有量95%」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-02170
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、76ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、イマザピルAPIのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
イマザピルAPIのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
イマザピルAPIの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
イマザピルAPIのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までのイマザピルAPIの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のイマザピルAPIの売上および2028年までの予測に焦点を当てています。

イマザピルAPIのグローバル主要企業には、CYNDA、BASF、Rainbowなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

イマザピルAPI市場は、タイプとアプリケーションによって区分されます。世界のイマザピルAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
含有量98%、含有量95%

【アプリケーション別セグメント】
農地除草、非耕作除草

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- イマザピルAPI製品概要
- タイプ別市場(含有量98%、含有量95%)
- アプリケーション別市場(農地除草、非耕作除草)
- 調査の目的
・エグゼクティブサマリー
- 世界のイマザピルAPI販売量予測2017-2028
- 世界のイマザピルAPI売上予測2017-2028
- イマザピルAPIの地域別販売量
- イマザピルAPIの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別イマザピルAPI販売量
- 主要メーカー別イマザピルAPI売上
- 主要メーカー別イマザピルAPI価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(含有量98%、含有量95%)
- イマザピルAPIのタイプ別販売量
- イマザピルAPIのタイプ別売上
- イマザピルAPIのタイプ別価格
・アプリケーション別市場規模(農地除草、非耕作除草)
- イマザピルAPIのアプリケーション別販売量
- イマザピルAPIのアプリケーション別売上
- イマザピルAPIのアプリケーション別価格
・北米市場
- 北米のイマザピルAPI市場規模(タイプ別、アプリケーション別)
- 主要国別のイマザピルAPI市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのイマザピルAPI市場規模(タイプ別、アプリケーション別)
- 主要国別のイマザピルAPI市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のイマザピルAPI市場規模(タイプ別、アプリケーション別)
- 主要国別のイマザピルAPI市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のイマザピルAPI市場規模(タイプ別、アプリケーション別)
- 主要国別のイマザピルAPI市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのイマザピルAPI市場規模(タイプ別、アプリケーション別)
- 主要国別のイマザピルAPI市場規模(トルコ、サウジアラビア)
・企業情報
CYNDA、BASF、Rainbow
・産業チェーン及び販売チャネル分析
- イマザピルAPIの産業チェーン分析
- イマザピルAPIの原材料
- イマザピルAPIの生産プロセス
- イマザピルAPIの販売及びマーケティング
- イマザピルAPIの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- イマザピルAPIの産業動向
- イマザピルAPIのマーケットドライバー
- イマザピルAPIの課題
- イマザピルAPIの阻害要因
・主な調査結果

imazapyr is an organic heterocyclic herbicide. It can be quickly absorbed by the roots and leaves of weeding in cultivated land. It can inhibit the biosynthesis of side chain amino acids of weeding in cultivated land, prevent weeds from growing and promote their death. The control targets include all weeds, but have no good herbicidal activity against sedge weeds, annual and perennial monocotyledons, broad-leaved weeds and miscellaneous weeds. Suitable for non-arable land and rubber plantation, oil palm, forest and tea plantation.
Market Analysis and Insights: Global Imazapyr API Market
Due to the COVID-19 pandemic, the global Imazapyr API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Content 98% accounting for % of the Imazapyr API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Farmland Weeding segment is altered to an % CAGR throughout this forecast period.
China Imazapyr API market size is valued at US$ million in 2021, while the US and Europe Imazapyr API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Imazapyr API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Imazapyr API include CYNDA, BASF and Rainbow, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Imazapyr API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Imazapyr API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Imazapyr API Scope and Segment
Imazapyr API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Imazapyr API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Content 98%
Content 95%
Segment by Application
Farmland Weeding
Non-arable Weeding
By Company
CYNDA
BASF
Rainbow
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Imazapyr API Product Introduction
1.2 Market by Type
1.2.1 Global Imazapyr API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Content 98%
1.2.3 Content 95%
1.3 Market by Application
1.3.1 Global Imazapyr API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Farmland Weeding
1.3.3 Non-arable Weeding
1.4 Study Objectives
1.5 Years Considered
2 Global Imazapyr API Production
2.1 Global Imazapyr API Production Capacity (2017-2028)
2.2 Global Imazapyr API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Imazapyr API Production by Region
2.3.1 Global Imazapyr API Historic Production by Region (2017-2022)
2.3.2 Global Imazapyr API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Imazapyr API Sales in Volume & Value Estimates and Forecasts
3.1 Global Imazapyr API Sales Estimates and Forecasts 2017-2028
3.2 Global Imazapyr API Revenue Estimates and Forecasts 2017-2028
3.3 Global Imazapyr API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Imazapyr API Sales by Region
3.4.1 Global Imazapyr API Sales by Region (2017-2022)
3.4.2 Global Sales Imazapyr API by Region (2023-2028)
3.5 Global Imazapyr API Revenue by Region
3.5.1 Global Imazapyr API Revenue by Region (2017-2022)
3.5.2 Global Imazapyr API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Imazapyr API Production Capacity by Manufacturers
4.2 Global Imazapyr API Sales by Manufacturers
4.2.1 Global Imazapyr API Sales by Manufacturers (2017-2022)
4.2.2 Global Imazapyr API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Imazapyr API in 2021
4.3 Global Imazapyr API Revenue by Manufacturers
4.3.1 Global Imazapyr API Revenue by Manufacturers (2017-2022)
4.3.2 Global Imazapyr API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Imazapyr API Revenue in 2021
4.4 Global Imazapyr API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Imazapyr API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Imazapyr API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Imazapyr API Sales by Type
5.1.1 Global Imazapyr API Historical Sales by Type (2017-2022)
5.1.2 Global Imazapyr API Forecasted Sales by Type (2023-2028)
5.1.3 Global Imazapyr API Sales Market Share by Type (2017-2028)
5.2 Global Imazapyr API Revenue by Type
5.2.1 Global Imazapyr API Historical Revenue by Type (2017-2022)
5.2.2 Global Imazapyr API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Imazapyr API Revenue Market Share by Type (2017-2028)
5.3 Global Imazapyr API Price by Type
5.3.1 Global Imazapyr API Price by Type (2017-2022)
5.3.2 Global Imazapyr API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Imazapyr API Sales by Application
6.1.1 Global Imazapyr API Historical Sales by Application (2017-2022)
6.1.2 Global Imazapyr API Forecasted Sales by Application (2023-2028)
6.1.3 Global Imazapyr API Sales Market Share by Application (2017-2028)
6.2 Global Imazapyr API Revenue by Application
6.2.1 Global Imazapyr API Historical Revenue by Application (2017-2022)
6.2.2 Global Imazapyr API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Imazapyr API Revenue Market Share by Application (2017-2028)
6.3 Global Imazapyr API Price by Application
6.3.1 Global Imazapyr API Price by Application (2017-2022)
6.3.2 Global Imazapyr API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Imazapyr API Market Size by Type
7.1.1 North America Imazapyr API Sales by Type (2017-2028)
7.1.2 North America Imazapyr API Revenue by Type (2017-2028)
7.2 North America Imazapyr API Market Size by Application
7.2.1 North America Imazapyr API Sales by Application (2017-2028)
7.2.2 North America Imazapyr API Revenue by Application (2017-2028)
7.3 North America Imazapyr API Sales by Country
7.3.1 North America Imazapyr API Sales by Country (2017-2028)
7.3.2 North America Imazapyr API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Imazapyr API Market Size by Type
8.1.1 Europe Imazapyr API Sales by Type (2017-2028)
8.1.2 Europe Imazapyr API Revenue by Type (2017-2028)
8.2 Europe Imazapyr API Market Size by Application
8.2.1 Europe Imazapyr API Sales by Application (2017-2028)
8.2.2 Europe Imazapyr API Revenue by Application (2017-2028)
8.3 Europe Imazapyr API Sales by Country
8.3.1 Europe Imazapyr API Sales by Country (2017-2028)
8.3.2 Europe Imazapyr API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Imazapyr API Market Size by Type
9.1.1 Asia Pacific Imazapyr API Sales by Type (2017-2028)
9.1.2 Asia Pacific Imazapyr API Revenue by Type (2017-2028)
9.2 Asia Pacific Imazapyr API Market Size by Application
9.2.1 Asia Pacific Imazapyr API Sales by Application (2017-2028)
9.2.2 Asia Pacific Imazapyr API Revenue by Application (2017-2028)
9.3 Asia Pacific Imazapyr API Sales by Region
9.3.1 Asia Pacific Imazapyr API Sales by Region (2017-2028)
9.3.2 Asia Pacific Imazapyr API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Imazapyr API Market Size by Type
10.1.1 Latin America Imazapyr API Sales by Type (2017-2028)
10.1.2 Latin America Imazapyr API Revenue by Type (2017-2028)
10.2 Latin America Imazapyr API Market Size by Application
10.2.1 Latin America Imazapyr API Sales by Application (2017-2028)
10.2.2 Latin America Imazapyr API Revenue by Application (2017-2028)
10.3 Latin America Imazapyr API Sales by Country
10.3.1 Latin America Imazapyr API Sales by Country (2017-2028)
10.3.2 Latin America Imazapyr API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Imazapyr API Market Size by Type
11.1.1 Middle East and Africa Imazapyr API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Imazapyr API Revenue by Type (2017-2028)
11.2 Middle East and Africa Imazapyr API Market Size by Application
11.2.1 Middle East and Africa Imazapyr API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Imazapyr API Revenue by Application (2017-2028)
11.3 Middle East and Africa Imazapyr API Sales by Country
11.3.1 Middle East and Africa Imazapyr API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Imazapyr API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 CYNDA
12.1.1 CYNDA Corporation Information
12.1.2 CYNDA Overview
12.1.3 CYNDA Imazapyr API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 CYNDA Imazapyr API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 CYNDA Recent Developments
12.2 BASF
12.2.1 BASF Corporation Information
12.2.2 BASF Overview
12.2.3 BASF Imazapyr API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 BASF Imazapyr API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 BASF Recent Developments
12.3 Rainbow
12.3.1 Rainbow Corporation Information
12.3.2 Rainbow Overview
12.3.3 Rainbow Imazapyr API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Rainbow Imazapyr API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Rainbow Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Imazapyr API Industry Chain Analysis
13.2 Imazapyr API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Imazapyr API Production Mode & Process
13.4 Imazapyr API Sales and Marketing
13.4.1 Imazapyr API Sales Channels
13.4.2 Imazapyr API Distributors
13.5 Imazapyr API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Imazapyr API Industry Trends
14.2 Imazapyr API Market Drivers
14.3 Imazapyr API Market Challenges
14.4 Imazapyr API Market Restraints
15 Key Finding in The Global Imazapyr API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer